good news iran: Iran-Cuba COVID-19 vaccine enters third phase of clinical trials

Tehran (ISNA) – The third phase of the clinical trials of a COVID-19 vaccine, jointly produced by the Pasteur Institute of Iran and the Finlay Institute of Cuba, began on Monday, April 26, in Isfahan City of Iran.

In the third phase of the clinical trials, approximately 20,000 people will receive the vaccine.

Photographer: Aria Jafari


Related Articles

Back to top button